Clinical Efficacy of Belotecan (CKD-602), Newly Developed Camptothecin Analog, in the 2nd Line Treatment of Relapsed Small Cell Lung Cancer (재발된 소세포폐암환자에서 이차 약제로 사용되는 Belotecan (CKD-602)의 임상적 효용성)
-
- Tuberculosis and Respiratory Diseases
- /
- v.66 no.2
- /
- pp.93-97
- /
- 2009